发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD |
摘要 |
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. |
申请公布号 |
EP2766020(A4) |
申请公布日期 |
2015.04.01 |
申请号 |
EP20120840715 |
申请日期 |
2012.10.11 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
HALLAK, HUSSEIN;TARCIC, NORA;FLAXMAN KAYE, JOEL |
分类号 |
A61K31/47;A61K31/035;A61K31/135;A61K31/137;A61K31/4704 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|